These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33122123)

  • 41. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.
    Zuraw BL; Cicardi M; Longhurst HJ; Bernstein JA; Li HH; Magerl M; Martinez-Saguer I; Rehman SM; Staubach P; Feuersenger H; Parasrampuria R; Sidhu J; Edelman J; Craig T
    Allergy; 2015 Oct; 70(10):1319-28. PubMed ID: 26016741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study.
    Zanichelli A; Ghezzi M; Santicchia I; Vacchini R; Cicardi M; Sparaco A; Donati G; Ranìa V; Busa A
    PLoS One; 2020; 15(3):e0230128. PubMed ID: 32163480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.
    Kőhalmi KV; Veszeli N; Zotter Z; Csuka D; Benedek S; Imreh É; Varga L; Farkas H
    Orphanet J Rare Dis; 2016 Feb; 11():18. PubMed ID: 26911866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
    Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States.
    Riedl MA; Banerji A; Busse PJ; Johnston DT; Davis-Lorton MA; Patel S; Parr H; Chiao J; Watson DJ; Burrell E; Machnig T
    Ann Allergy Asthma Immunol; 2017 Jul; 119(1):59-64. PubMed ID: 28668241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
    Magerl M; Germenis AE; Maas C; Maurer M
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.
    Otani IM; Christiansen SC; Busse P; Camargo CA; Zuraw BL; Riedl MA; Banerji A
    J Allergy Clin Immunol Pract; 2017; 5(1):128-134.e4. PubMed ID: 27665386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facilitating home-based treatment of hereditary angioedema.
    Bernstein JA; Riedl M; Zacek L; Shapiro RS
    Allergy Asthma Proc; 2015; 36(2):92-9. PubMed ID: 25551795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K; Bernstein JA; Machnig T; Craig TJ
    J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
    Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
    Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
    Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I
    Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema.
    Busse PJ; Christiansen SC; Riedl MA; Banerji A; Bernstein JA; Castaldo AJ; Craig T; Davis-Lorton M; Frank MM; Li HH; Lumry WR; Zuraw BL
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):132-150.e3. PubMed ID: 32898710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
    Bernstein JA
    Am J Rhinol Allergy; 2013; 27(6):522-7. PubMed ID: 23866957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries.
    Toubi E; Kivity S; Graif Y; Reshef A; Botha J; Andresen I
    Isr Med Assoc J; 2018 Apr; 20(4):227-232. PubMed ID: 29629730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].
    Fukunaga A; Morita E; Miyagi T; Eto K; Shimizu A; Kagami S; Yamamoto H; Vardi M; Tang Y; Wang Y; Hide M
    Arerugi; 2020; 69(3):192-203. PubMed ID: 32435020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.